Ironwood Pharmaceuticals Inc

I76

Company Profile

  • Business description

    Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

  • Contact

    100 Summer Street
    Suite 2300
    BostonMA02110
    USA

    T: +1 617 621-7722

    E: [email protected]

    https://www.ironwoodpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    253

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,774.8086.801.00%
CAC 407,615.9978.421.04%
DAX 4023,641.58372.571.60%
Dow JONES (US)43,107.09525.311.23%
FTSE 1008,758.990.950.01%
HKSE24,177.07487.942.06%
NASDAQ19,937.20306.231.56%
Nikkei 22538,790.56436.471.14%
NZX 50 Index12,467.4865.17-0.52%
S&P 5006,095.3170.141.16%
S&P/ASX 2008,555.5080.600.95%
SSE Composite Index3,420.5738.981.15%

Market Movers